Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
Lilly Announces Leadership Transition in Human Resources and New Chief Commercial Officer for Loxo@Lilly
Eli Lilly and Company (NYSE: LLY) today announced the upcoming retirement of one executive committee member, […]
Laronde Appoints John Mendlein as Chief Executive Officer
Laronde, the company pioneering Endless RNA™ (eRNA) – a novel, engineered form of RNA that […]
Ginkgo Bioworks Appoints Kathy Hopinkah Hannan to its Board of Directors
Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced that Kathy […]
DetectaChem/MD-Bio Introduce Assay for Monkeypox Detection
DetectaChem and its subsidiary MD-Bio, the global leaders in innovative threat detection solutions used extensively […]
Regard and TidalHealth Partner To Fight Clinician Burnout Through AI-Driven Workflows
Regard, a software company developing an artificial intelligence (AI) co-pilot for physicians to help diagnose […]
NHS to Roll Out Life-changing Glucose Monitors to All Type 1 Diabetes Patients
NHS England patients with Type 1 diabetes will now be eligible for life-changing continuous glucose […]
Novogene America Launches a New Single-Cell Lab in San Jose. CA, Based on Chromium Platform Powered by 10x Genomics®
High-throughput sequencing methods mainly based on Illumina platforms have benefited the entire field of biology […]
Pediatric Medical Centers Improve the Efficiency of Investigator-Initiated, Multi-Site, Collaborative Research with TriNetX
TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of […]
PayGround Raises $5.5M in Latest Funding Round
PayGround, a healthcare fintech payments platform, today announced the completion of a $5.5M funding round led by FCA […]
Ginkgo to Acquire Zymergen
Today, Ginkgo Bioworks (NYSE: DNA) — the leading horizontal platform for cell programming — and […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more